Literature DB >> 9078587

Vaccination of different strains of mice against cutaneous leishmaniosis: usefulness of membrane antigens encapsulated into liposomes by intraperitoneal and subcutaneous administration.

C M Lezama-Dávila1.   

Abstract

The objective of this study was to assess the usefulness of parasite-surface molecules reconstituted into liposomes to vaccinate four different strains of mice (C57BL/10, CBA/ca, C57BL/6 and NZB) with different levels of susceptibility to L. m. mexicana infection and to find out possible increases in specific antibody response after vaccination, but before infection with virulent promastigotes. Mice were vaccinated with parasite membrane antigens incorporated into liposomes and antibody levels were recorded. Vaccination was effective to protect CBA/ca and C57BL/6 but not C57BL/10 mice and NZB animals were naturally resistant. Intraperitoneal (ip) was more effective than the subcutaneous (sc) route of inoculation, and the induction of disease-resistance correlated with the production of IgG anti-Leishmania in CBA/ca, C57BL/6 and C57BL/10 mice.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9078587

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  4 in total

1.  Hyper IgE in New Zealand black mice due to a dominant-negative CD23 mutation.

Authors:  Graham Lewis; Eleni Rapsomaniki; Tiphaine Bouriez; Tanya Crockford; Helen Ferry; Robert Rigby; Timothy Vyse; Teresa Lambe; Richard Cornall
Journal:  Immunogenetics       Date:  2004-10-19       Impact factor: 2.846

2.  Comparative evaluation of two vaccine candidates against experimental leishmaniasis due to Leishmania major infection in four inbred mouse strains.

Authors:  Fouad Benhnini; Mehdi Chenik; Dhafer Laouini; Hechmi Louzir; Pierre André Cazenave; Koussay Dellagi
Journal:  Clin Vaccine Immunol       Date:  2009-09-02

3.  Mimetic membrane system to carry multiple antigenic proteins from Leishmania amazonensis.

Authors:  Fabiana R Santos; Denise B Ferraz; Katia R P Daghastanli; F Juarez Ramalho-Pinto; Pietro Ciancaglini
Journal:  J Membr Biol       Date:  2006-08-14       Impact factor: 2.426

4.  Differential Toxicity of Antibodies to the Prion Protein.

Authors:  Regina R Reimann; Tiziana Sonati; Simone Hornemann; Uli S Herrmann; Michael Arand; Simon Hawke; Adriano Aguzzi
Journal:  PLoS Pathog       Date:  2016-01-28       Impact factor: 6.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.